By Admin at 3 Mar 2016

Colorectal cancer is expected to cause nearly 50,000 deaths during 2016. Phase I and Phase II human clinical trials offer the best hope for finding new breakthrough cures, yet they are among the most underfunded. Please take a moment to discover how an innovative Gateway-funded clinical trial is saving lives of patients with colorectal cancer right now!